Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drug, Healthcare and Patient Safety|May 2, 2018
Evaluating cardiac risk: exposure response analysis in early clinical drug developmentJulie Grenier, Sabina Paglialunga, Bruce H Morimoto, et al.
Therapeutic Drug Monitoring|September 14, 2011
Performance of different population pharmacokinetic algorithmsPhilippe Colucci, Julie Grenier, Corinne Seng Yue, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humansJulie Grenier, Caroline Fradette, Gaetano Morelli, et al.
Journal of Visualized Experiments : Jove|July 22, 2014
Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantationInsaf Salem Fourati, Anne-Julie Grenier, Élyse Jolette, et al.
The Canadian Journal of Cardiology|August 12, 2009
Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizuresDagmar I Keller, Julie Grenier, Georges Christé, et al.
Journal of Clinical Pharmacology|April 25, 2015
Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjectsLinh Nguyen, Jaymes Holland, Richard Mamelok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2010
Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cellsNatacha Merindol, Anne-Julie Grenier, Martine Caty, et al.
Clinical Pharmacology in Drug Development|October 15, 2016
Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult SubjectsMichael Burdick, Richard Mamelok, Michele Hurliman, et al.
Pageof 1